- 
                        April - June 2021 | Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS)
                        29 Aug 2025 20:22 GMT
                        
                           …  time based on available information.
                          Arzerra (ofatumumab)
                          Gazyva (obinutuzumab)
                          Riabni  …  zirconium cyclosilicate)
                          Gastrointestinal disorders
                          FDA determined that no action is … .
                          Sarclisa labeling
                          Sprycel (dasatinib)
                          Drug-induced liver injury
                          The “Warnings …
                        
                       
                      - 
                        Blood Cancer Treatment Market Sees Accelerated Growth Across the 7MM Amid Rising Incidence and Breakthroughs | DelveInsight
                        12 May 2025 17:00 GMT
                        
 …  medicine is transforming treatment … RITUXAN, ARZERRA, and … trials. Pharmaceutical companies are actively pursuing innovative treatments … drugs in development @ Chronic Lymphocytic Leukemia Clinical Trials Chronic Myeloid Leukemia Market Chronic myeloid leukemia …
                       
                      - 
                        Betaseron interactions: Alcohol, medications, and other factors
                        28 Feb 2025 14:06 GMT
                        
                           … medications together.
                          Examples of HIV drugs: Here are some HIV drugs … 
                          ofatumumab (Arzerra, Kesimpta)
                          Steps you or your doctor may take …  treatment with Betaseron, talk with your doctor.
                          Betaseron and vaccines … t been enough clinical trials to determine whether  …
                        
                       
                      - 
                        Strategies for Non-Covalent Attachment of Antibodies to PEGylated Nanoparticles for Targeted Drug Delivery
                        01 Oct 2024 05:24 GMT
                        
 … of nanomedicine and biotechnology holds promise  … -Drug Conjugates Using Cysteine Insertion. Mol Pharmaceut. … Medicines Agency review of ofatumumab (Arzerra(R)) for the treatment of chronic lymphocytic leukemia … Du L. Subunit Vaccines Against Emerging Pathogenic …
                       
                      - 
                        New Drug Therapy Approvals 2020
                        17 Jun 2024 18:46 GMT
                        
 …  medication that is taken as a single dose in pill  …  agreed to with the pharmaceutical industry and approved by  … name, Arzerra—to treat certain patients with chronic lymphocytic leukemia. Its … is the first drug treatment approved by the FDA for mesothelioma in …
                       
                      - 
                        Chronic Lymphocytic Leukemia Market Forecast 2032: FDA Approvals, Clinical Trials, Drugs and Companies, by DelveInsight
                        18 Jun 2024 14:01 GMT
                        
                           … , MingSight Pharmaceuticals, Nurix  … drug.
                          Chronic Lymphocytic Leukemia Drugs Uptake helps in understanding the drugs … Leukemia Clinical Trials and FDA Approvals
                          
                          Chronic Lymphocytic Leukemia …  Leukemia Treatment Algorithm, Current Treatment, and Medical  …
                        
                       
                      - 
                        9 biotech companies leading the way in Denmark
                        26 Mar 2024 18:36 GMT
                        
                           …  medical need for a vaccine against …  with biotechnology and pharmaceutical companies, … treatment of multiple myeloma, Arzerra (ofatumumab), which is indicated for chronic lymphocytic leukemia … treatment with certain chemotherapy drugs.
                          IO Biotech
                          IO Biotech …
                        
                       
                      - 
                        Arzerra dosage
                        08 Mar 2024 16:04 GMT
                        
                           … name drug prescribed for chronic lymphocytic leukemia (CLL) in some adults. Arzerra comes …  severity.
                          Arzerra is approved by the Food and Drug Administration (FDA) for … Doctors may prescribe Arzerra as a first treatment for CLL if fludarabine-based medications …
                        
                       
                      - 
                        Bexsero interactions: Alcohol, medications, and other factors
                        10 Jan 2024 18:24 GMT
                        
                           …  receiving Bexsero, tell your doctor about other medications you take. They’ll …  treatment may weaken your immune system. Receiving Bexsero while taking this drug …  doctor before receiving this vaccine.
                          Pregnancy: There haven’t been enough clinical trials …
                        
                       
                      - 
                        3 Biotech Companies to Watch in 2023
                        07 Jan 2023 00:33 GMT
                        
 …  and precision medicine, biotech companies have  … drug design. Offering some of the most revolutionary medicines … treatments for some of the world’s greatest medical challenges, Vertex Pharmaceuticals … cancer, while Arzerra tackles leukemia and multiple  …